Neuroimaging and post-mortem studies indicate that chronic alcohol use induces global changes in brain morphology, such as cortical and subcortical atrophy. Recent studies have shown that frontal lobe structures are specifically susceptible to alcohol-related brain damage and shrinkage in this area is largely due to a loss of white matter. This may explain the high incidence of cognitive dysfunction observed in alcoholics. Using a proteomics-based approach, changes in protein expression in the dorsolateral prefrontal region (BA9) white matter were identified in human alcoholic brains. Protein extracts from the BA9 white matter of 25 human brains (10 controls; eight uncomplicated alcoholics; six alcoholics complicated with hepatic cirrhosis; one reformed alcoholic) were separated using two-dimensional gel electrophoresis. Overall, changes in the relative expression of 60 proteins were identified (Po0.05, ANOVA) in the alcoholic BA9 white matter. In total, 18 protein spots have been identified using MALDI-TOF; including hNP22, a-internexin, transketolase, creatine kinase chain B, ubiquitin carboxy-terminal hydrolase L1 and glyceraldehyde-3-phosphate dehydrogenase. Several of these proteins have been previously implicated in alcohol-related disorders and brain damage. By identifying changes in protein expression in this region from alcoholics, hypotheses may draw upon more mechanistic explanations as to how chronic ethanol consumption causes white matter damage.
Introduction
Neuroimaging and post-mortem studies indicate global changes in brain morphology of chronic alcoholics, such as cortical and subcortical atrophy. [1] [2] [3] There is evidence that frontal lobe structures, such as the dorsolateral prefrontal cortex (BA9), are specifically altered in alcohol-related brain damage. Neuropsychological assessments of neurologically normal alcoholics have reported selective alterations of frontal executive functions, such as planning or problem-solving ability. 4 An alcoholic-selective frontal dysfunction is also supported by functional imaging studies, where glucose hypometabolism has been reported in the mediofrontal cortex. 5, 6 Furthermore, neuronal loss and a reduction in basal dendritic arborisation were described in the superior frontal cortex of alcoholics. 1 Together, these pathological findings may help explain the functional changes and cognitive deficits, which are frequently observed in alcoholic patients.
Cortical white matter loss is suggested to be largely responsible for brain shrinkage associated with alcoholism and some of this damage appears to be reversible after prolonged abstinence. 7, 8 CT and MRI observations of reduced white matter volumes in alcoholics 2, 3 have been confirmed by quantitative pathological studies. 9 In a volumetric study, Kril et al. 10 demonstrated a negative correlation between white matter volume and maximum daily alcohol intake. Alcohol-related white matter loss may underlie the observed shrinkage and cognitive deficits associated with the frontal lobes. Using 1H magnetic resonance spectroscopy (MRS), Schweinsburg et al., 11 showed a significant reduction of the metabolite Nacetyl aspartate in frontal white matter of recently detoxified alcoholics. Brain volume analyses revealed that white matter in alcoholics with WernickeKorsakoff Syndrome (WKS) is most markedly reduced in the prefrontal region. 10 Although the nature of this change has not yet been elucidated, it is likely that this disruption involves changes in both myelination and axonal integrity. of complex disorders. However, importantly, mRNA is not the functional end point of gene expression and mRNA abundance has been shown to be a poor indicator of the levels of corresponding protein. 14, 15 Proteins are uniquely modified in ways that are not apparent from the gene sequence, that is, by differential splicing, post-translational modifications and protein-protein interactions. In addition, analysis by microarray technology is limited to the cellular component of the tissue examined.
Proteomics is rapidly achieving recognition as a complimentary and perhaps superior approach to examine global changes in protein expression in complex biological systems. Using such methods, Lewohl, et al. 16 found 182 significant changes in protein expression in the alcoholic superior frontal cortex (pooled samples, mixture of grey/white matter). In the present study, we used a proteomics-based approach, coupling two-dimensional (2D) gel electrophoresis with powerful image analysis software and mass spectrometry, to analyse protein expression profiles of white matter from the BA9 region. By identifying changes in protein expression in this region from alcoholics, hypotheses may draw upon more mechanistic explanations as to how chronic ethanol consumption causes brain damage.
Materials and methods

Human brain tissue
The NSW Tissue Resource Centre, University of Sydney, provided white matter adjacent to the dorsolateral prefrontal cortex (BA9; region immediately anterior to the genu of the corpus callosum; 17) from 25 freshly frozen human brains. Cases were classified into four groups: (A) normal control cases (o20 g of ethanol/day; n ¼ 10), (B) uncomplicated alcoholics (480 g of ethanol/day; no post-mortem finding of cirrhosis or WKS; n ¼ 8), (C) alcoholics complicated with hepatic cirrhosis (480 g of ethanol/ day; hepatic cirrhosis confirmed postmortem, no indication of WKS; n ¼ 6), and (D) reformed alcoholic (daily consumption of 120 grams of beer for 10 years; abstained from alcohol last 14 years of life; no cirrhosis or WKS confirmed at autopsy; n ¼ 1). Cases with a recent history of coma or any other medical illness that may affect the agonal state of the patient were ruled out. Additionally, brain pH was assessed to indicate the agonal status of the tissue. Control cases presented no neurological or neuropathological abnormalities upon post-mortem examination and had no history of major psychiatric illness. Four control cases have no history of alcohol consumption (lifetime consumption is 0 kg of 100% ethanol). All alcoholic cases fulfilled the criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) for alcohol abuse disorder. 17, 18 Lifetime alcohol consumption was calculated from an average of the amount reported by next of kin and/or from medical records. Cases were matched for age, sex and postmortem interval (PMI) as closely as possible; however, the mean PMI for controls was shorter (23.174.24 h) than the uncomplicated and complicated alcoholic groups (38.476.52 and 41.877.56 h, respectively). Details of each case are listed in Table 1 . Approval from the Central Sydney Area Health Service (Protocol no. X03-00285) was obtained for the use of human post-mortem brain tissue in this study.
Preparation of protein extract
Approximately, 100 mg of fresh frozen human brain tissue was homogenised with 1 ml of Buffer 1 (7 M urea, 2 M thiourea, 1% C7bZO and 40 mM Tris). The suspension was sonicated four times at 70% intensity/100% cycle in 10 s bursts and then pelleted at 16 000 g for 20 min at 151C. The supernatant was reduced and alkylated in 5 mM tributyl phosphine and 10 mM acrylamide monomer at room temperature for 2 h. The reaction was quenched using dithiothreitol (DTT) to 10 mM. The extract was precipitated using acetone and 20 mg citric acid. The precipitation was allowed to proceed for 5 min and then centrifuged at 2500 g for 15 min at 151C. The pellet was air dried and resuspended in 1 ml of Buffer 2 (7 M urea, 2 M thiourea and 1% C7bZO). The final extract was aliquoted and stored at À201C before isoelectric focusing.
2D gel electrophoresis
Protein concentration was determined by the Bradford method 19 using a complex protein mixture (extracted from the same human brain region and freeze dried) as a standard. Immobilised pH gradient strips (IPG strips, 11 cm, pH 3-10, Proteome Systems), were re-hydrated with samples (run in duplicate) containing 200 mg of protein for 6 h at room temperature. The re-hydrated strips were focused using the ElectrophoretIQ 3 system (Proteome Systems) for a total of 120 kVh. IPG strips were equilibrated using ProteomIQt SDS equilibration buffer and loaded onto SDS-PAGE gels (GelChipt, 2D, 6-15%, 10x15 cm; Proteome Systems) for second dimension separation by the ElectrophoretIQ 3 system (50 mA/gel, 151C for 90 min; Proteome Systems). Gels were fixed in a solution containing 25% (v/v) methanol and 2.5% (w/v) ortho-phosphoric acid and stained using colloidal Coomassie Blue.
Image analysis
The resultant 50 gels (25 samples run in duplicate) were scanned using a transmissive, flatbed scanner (UMAX) and analysed using Phoretix 2D Expression software (Nonlinear). Averaged gels were created for each disease/control group to assist comparison and reduce case-case variation. Averaging parameters were set at 70%, i.e. for a spot to appear in the averaged gel, it must occur in 70% of all gels in the case group. One-way Analysis of Variance (ANOVA) tests were used to reveal whether expression differences were statistically significant between the control and the alcoholic groups. Pearson correlations were used to determine the effect of age and PMI on spot volumes. Spots of interest were recovered for identification by mass spectrometry.
Mass spectrometry and database searching Protein spots of interest were excised and de-stained using 25 mM NH4HCO3/50% (v/v) acetonitrile (ACN) for 3 Â 15 min at 371C. The gel spots were then dehydrated using 100% ACN. For trypsin digestion, the gel pieces were re-swollen in 3 volumes of 12.5-ng/ml trypsin (Roche, sequencing grade) in 25 mM NH4HCO3/ 0.1% TFA, covered with 25 mM NH4HCO3 and incubated overnight at 371C. The peptide mixtures were purified from the supernatant using C-18 purification tips (Eppendorf). The sample was eluted from the purification tip onto a MALDI sample plate with 3 mL of Matrix (5 mg/mL solution of a-cyano-4-hydroxy-cinnamic acid in 70%(v/v) ACN/ 0.1%(v/v) TFA) and allowed to air dry. Samples were then analysed using an Applied Biosystems Voyager System MALDI-TOF 4038 in positive reflector mode, with delayed extraction.
The peptide peak masses were entered in the peptide mass fingerprint search form at http:// www.matrixscience.com. This search tool compares 
Results
Changes in protein expression
The normal control averaged gel showed 756 spots (20 gels); the uncomplicated alcoholics averaged gel had 643 spots (16 gels); the alcoholics complicated with hepatic cirrhosis averaged gel had 657 spots (12 gels); the recovered alcoholic averaged gel (two gels) 658 spots. Comparison between gels can be limited by the ability to match spots between case groups and averaged gels. In this study, more than 93% of all spots were matched to the reference gel allowing excellent comparison across all case groups. Changes in the relative expression of 60 protein spots were identified in the alcoholic BA9 white matter (Po0.05; ANOVA). In all, 40 (67%) of these had decreased expression in both the uncomplicated and complicated with hepatic cirrhosis alcoholic groups. In the uncomplicated alcoholic group, 12 spots changed by more than 1.5-fold of control levels, 12 spots had a 1.3-1.5-fold change and three spots were absent all together. The alcoholics complicated with hepatic cirrhosis group had 21 spots change by more than 1.5-fold of control levels, 18 spots with a 1.3-1.5-fold change and one absent spot. In all, 30 spot changes present in the uncomplicated alcoholic group also reached significance in the alcoholics complicated with cirrhosis group (see Figure 1 and Table 2 for summary). Interestingly, many of the differences seen in the uncomplicated alcoholic group were exacerbated in the alcoholics complicated with cirrhosis group, although not all changes were significant. An image highlighting the decreased expression of a particular spot in the uncomplicated and complicated alcoholics is illustrated in Figure 2 . Of the 60 changes, four spots showed a correlation to PMI (0.16o r 2 o0.24, Po0.05) and four to the age of the patient (0.23o r 2 o0.27, Po0.05). One of the agerelated spots (No. 319; r 2 ¼ 0.166, P ¼ 0.048) was identified as Dihydropyramidinase (DRP-2). Three other forms of this protein were identified in this study, none of which demonstrates any correlation to age or PMI.
As only one recovered alcoholic case was available for analysis, results could not be included in any meaningful statistical analysis. However, the expression pattern of this case revealed some interesting findings. Many of the spots that changed significantly in the other alcohol groups, that is, DRP-2, were seen to return to similar levels to controls, an example of which is shown in Figure 3 . This emphasises the need for further analysis of this type of case but they are difficult for brain banks to collect and characterise.
Protein identification
Eighteen protein spots have been identified using MALDI-TOF and are summarised in Table 3 . Some spots were identified as the same protein and these may represent different isoforms or post-translational modifications, an example of which is illustrated in Figure 4 . The remaining spots will be subjected to LC/ MS, a more sensitive mass spectrometry method, for identification.
Discussion
This data suggests that significant changes in protein expression occur in a region of the prefrontal white matter (BA9) that is thought to be abnormal both structurally and functionally in chronic Common spot changes Figure 1 Summary of significant protein expression changes in the uncomplicated and complicated with hepatic cirrhosis alcoholic groups. Proteomics of human alcoholic prefrontal cortex K Alexander-Kaufman et al alcoholics.
2,3,9-11 A general decline in the expression of differentially expressed proteins was documented in alcoholic brains. Average PMIs for both alcoholic groups were longer than the control group and this may suggest some post-mortem degradation. However, previous studies have also described reduced expression in alcoholic brains. 16, 20 In particular, Lewohl et al. 16 demonstrated a trend for lower protein expression in alcoholic samples with a shorter mean PMI than controls (27 h in alcoholics, 41 h in controls). In this study, no correlation was found between the PMI and expression levels for the majority of significant spot changes. Therefore, the overall decreased level of protein expression in alcoholic brains seen here is likely a reflection of disease-specific changes rather than an effect of degradation.
Interestingly, many of the proteins identified here are metabolic enzymes important for energy transduction (i.e. Creatine Kinase chain B, NADH 2 ubiquinone, fructose-bisphosphate aldolase C and glyceraldehyde-3-phosphate dehydrogenase). Most of these enzymes have reduced expression in both the uncomplicated and complicated alcoholic groups. The depletion of these enzymes may alter a cell's capacity to fulfil its metabolic functions, leading to a loss of viability. Using 21 assessed the effect of chronic ethanol exposure on different aspects of metabolism in cultured rat astrocytes and identified decreased ATP and phosphocreatine levels and altered amino-acid uptake and release. 21 This suggests an enhancement of the glutathione demand, which is compatible with an ethanol-induced response to oxidative stress. 21 Many studies have demonstrated that ethanol and/or its metabolic products interact directly at the DNA level, leading to a potentially lethal disruption of genomic function. [22] [23] [24] Ikegami et al. detected DNA fragmentation, selectively localised to glial cells, in the superior frontal cortex and the hippocampus of 22 Some identified proteins in this study have been previously implicated in alcohol-related disorders and brain damage. A proteomics study comparing pooled samples of alcoholic superior frontal cortex to control tissue (no separation between grey and white) also demonstrated a decrease in the expression of ubiquitin carboxy-terminal hydrolase L-1 (UCH L-1) and creatine kinase chain B (CK-B) . 16 These two proteins were shown to be specific targets of oxidisation in Alzheimer's disease. 26 UCH L-1 activity is crucial for proteolytic degradation and has been implicated in the aetiology of neurodegeneration. For instance, the gracile axonal dystrophy mutant mouse, which represents a deletion within the UCH L-1 gene, displays axonal degeneration. 27 Decreased activity of this enzyme may contribute to depleting the activity of the whole machinery responsible for degrading damaged proteins, 26 the accumulation of which may be important in degenerative processes. CK-B reversibly catalyses the transfer of phosphate between ATP and various phosphogens (e.g. creatine phosphate) and CK isoenzymes play a central role in energy transduction in tissues with large fluctuating energy demands like the brain. 28 Using magnetisation transfer techniques, creatine kinase activity was shown to be reduced in rat brains following chronic alcohol intoxication. 29 This together with the decreased expression of CK-B in alcoholic BA9 white matter suggests a role for CK-B in alcohol-related brain damage.
Human neuronal protein 22 (hNP22) is a hydrophilic, cytoplasmic protein that is suggested to interact with cytoskeletal proteins. 30 Expression of hNP22 in non-neuronal cells results in dramatic changes in cell shape and cytoskeletal organisation. 31 Immunohistochemistry revealed hNP22 expression is restricted to the cytoplasm and processes of neurons in all layers of the prefrontal cortex, with no reactivity found in the glial component. 32 Recently, a significant elevation in hNP22 levels was demonstrated in the grey matter of the same region (BA9) in alcoholics. 32 A decrease in white matter hNP22 expression levels observed in this study might therefore be indicative of a disturbance in the axonal transport of this protein.
Further investigation into the function of hNP22 is required to support such a hypothesis. a-Internexin is one of five major intermediate filament proteins that are important for the neuronal cytoskeleton. 33 The abnormal accumulation of intermediate filament proteins is a pathological hallmark of many human neurodegenerative diseases, that is, Amyotrophic lateral sclerosis, Parkinson's disease, dementia with Lewy bodies and neuropathies. 33, 34 Following their synthesis in the perikaryon, neurofilament proteins are swiftly assembled into filamentous structures and translocated into the axons. 33 The decreased expression of a-internexin in the alcoholic groups is consistent with brain shrinkage and neuronal death and this together with the decline in hNP22 expression indicates that chronic alcohol use has specific effects on the cytoskeleton.
Investigations in humans and animals have implicated a reduction in the activation of thiamine utilising enzymes as the metabolic basis of tissue injury due to thiamine deficiency, 35 which is extremely common in alcoholics. 36 Transketolase, decreased in both alcoholic groups here, is an enzyme that requires thiamine pyrophosphate (TPP) as a cofactor and has been previously implicated in WKS. 37, 38 Transketolase derived from fibroblasts of alcoholic patients with WKS has been shown to have a decreased affinity for TPP. 37 A nonoptimally functioning transketolase might be expected to alter the cell's capacity to fulfil its metabolic functions, thus affecting lipid and other syntheses, reduced glutathione production and perhaps amino-acid production and transport. 37 Interestingly, thiamine deficiency, measured by erythrocytic transketolase activity, has been reported in up to 80% of alcoholic patients, however, only a subset of these patients manifest the autopsy findings attributed to WKS. 39, 40 It is possible that at some level, all alcoholics are thiamine deficient, as indicated in this study by a reduction in transketolase levels, and diagnostic criteria for WKS are not stringent enough to pick up subclinical thiamine deficiencies or early stages of this syndrome. This very important issue should be considered for future post-mortem studies. It should be noted that alcohol-related thiamine deficiency is potentially preventable and easily treated if identified clinically. 36, 41 Fructose-bisphosphate aldolase C (brain-type aldolase) and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) are glycolytic enzymes also important in cell metabolism. Changes in GAPDH, aldolase and transketolase, documented here in alcoholic brains, may reflect a crosstalking between the glycolysis and pentose phosphate pathways via common intermediates. 42 The interconnection of these pathways may provide compensatory shifts in energy metabolism while the cell is under stress. Again, changes in these enzymes in alcoholic brains indicate that metabolic disturbances may be important in alcohol-related brain damage. Recent evidence indicates that GAPDH displays a number of diverse activities unrelated to its glycolyic function. 43, 44 Most interesting in this instance is GAPDH's role in initiating neurodegenerative processes. Oxidative stress, a mechanism important in alcohol-related brain damage, is suggested to induce GAPDH through its unique interaction with nitric oxide. 45 Increased levels of GAPDH in the BA9 white matter of alcoholics may therefore play an important role in initiating brain damage caused by chronic alcoholism through this cascade.
NADH 2 ubiquinone is important for oxidative phosphorylation and a change in ubiquinone levels infers an alteration in metabolic processes and possible mitochondrial dysfunction. 46 Although ubiquinone levels have been shown to decrease significantly in all parts of the brain upon ageing, 47 with case matching and gel averaging these effects should not confound alcohol-related changes. However, differential expression of this protein is inconsistent between the uncomplicated alcoholics and alcoholics with hepatic cirrhosis. These results must be substantiated using other techniques before any meaningful inferences can be drawn.
Four different forms of dihydropyramidinase-related protein 2 (DRP-2) were identified. The expression levels of two of these were increased and two were decreased in both alcoholic groups. DRP-2 is involved in the process of axonal outgrowth mediated by extracellular signals 48 and its expression in the adult brain is suggested to be important as a mechanism of repair and regeneration of adult neurons. 49 Furthermore, depressed levels of this protein have been shown in schizophrenia and Down's syndrome 50, 51 and increased levels of DRP-2 carbonyls were detected in brains from Alzheimer's disease patients. 49 DRP-2 is often seen as multiple spots on 2D gels and the ratio between the truncated form and full-length form is suggested to be a biomarker of post-mortem temperature and time. 52 A decrease in DRP-2 levels were described within the first 6 h postmortem, along with the appearance of 22 new spots representing shorter forms of the protein. 53 No correlation between DRP-2 levels and PMI was seen in this study; however, one form of DRP-2 (no. 319) did show some relation to patient age. Ages were well matched between case groups (56.7, 61.5 and 56.5 years for controls, uncomplicated and complicated alcoholics respectively), thus changes in DRP-2 levels are likely to be disease related. Further investigation is necessary to determine the role of DRP-2 in ageing and alcohol-related brain damage.
Two different spots were identified as vacuolar ATPase subunit B (brain isoform), both of which were decreased in the uncomplicated and complicated alcoholic groups. The function of this protein is responsible for acidifying a variety of intracellular compartments along the secretory pathway. Wang and Floor, 54 showed that V-ATPase in bovine brain synaptic vesicles is highly sensitive to inhibition by micromolar concentrations of H 2 O 2 . This suggests that V-ATPase may function as a redox sensor that regulates transmitter storage in response to oxidative stress. 54 As oxidative stress is proposed as an important mechanism in alcohol-related brain damage, 55 further examination into the effects of alcohol on V-ATPase may provide some interesting insights. Porphobilinogen synthase or d-aminolevulinic acid dehydratase (dALAD) is the second enzyme in the porphyrin-heme pathway. 56 Ethanol has been shown to decrease the activity of dALAD, 57 possibly through ethanol's conversion into acetaldehyde, a true inhibitor of dALAD. However, DTT, the reagent used to quench the alkylation and reduction reaction in the protein extraction step in this study, has been shown to restore dALAD activity and reverse V-ATPase inhibition described above. Although control and disease samples received the same treatment, because of this interaction, the differential expression of these enzymes cannot be attributed to alcohol-related brain damage without further investigation.
Many of the differences seen in the uncomplicated alcoholic group were exacerbated in the alcoholics complicated with cirrhosis group. Alcoholics frequently develop severe hepatic dysfunction, that is, hepatic cirrhosis, and this per se results in altered thiamine homeostasis, cognitive dysfunction and damage to astrocytes. 58 Thus, hepatic cirrhosis can induce brain damage and this additional factor may explain this trend of increased intensity.
The expression profile of the recovered alcoholic case revealed an important avenue for further study. Several of the spots that changed significantly in the uncomplicated and complicated alcoholic groups were seen to return to comparable expression levels of controls. Of the identified spots, ubiquinone and some forms of DRP-2 and V-ATPase returned to control levels. These proteins may be important for the proposed regeneration of white matter described after prolonged abstinence from alcohol. 9 Using quantitative MRI, O'Neill et al. 59 demonstrated increased frontal white matter volumes in recovering alcoholics. Also, a recent 31 P MRS study found partial recovery of chronic alcohol-induced white matter phospholipid damage with long-term abstinence. 60 However, this study suggests there is a persistent abnormality in the nature and/or physical properties of white matter phospholipids in abstinent alcoholics. 60 Proteins that did not return to control levels in this study may be implicated in enduring neuronal plasticity. Of the spots identified, some forms of DRP-2 and V-ATPase, transketolase, a-internexin, CK-B, aldolase C, GAPDH, dALAD, UCH-L1 and hNP22 levels were similar to the uncomplicated and complicated alcoholic groups. Investigating these changes in protein expression with additional 'recovered alcoholic' cases will help elucidate mechanisms for white matter regeneration and plasticity.
Conclusions
In summary, we have identified a number of differentially expressed proteins in the alcoholic prefrontal lobe white matter (area BA9), some of which have been previously implicated in alcohol-related disorders and brain damage. Understanding the regulation of these protein systems disrupted in alcoholism will ultimately provide new mechanistic explanations for the pathophysiology of alcohol-related brain damage.
